Call Options

11 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$22.17 - $51.8 $2.22 Million - $5.18 Million
-100,000 Reduced 63.49%
57,500 $2.97 Million
Q2 2022

Aug 15, 2022

SELL
$15.36 - $27.51 $2.42 Million - $4.33 Million
-157,400 Reduced 49.98%
157,500 $3.9 Million
Q1 2022

May 13, 2022

BUY
$22.22 - $39.12 $5.66 Million - $9.97 Million
254,900 Added 424.83%
314,900 $7.89 Million
Q4 2021

Feb 11, 2022

SELL
$18.38 - $40.5 $22 Million - $48.6 Million
-1,199,500 Reduced 95.24%
60,000 $2.19 Million
Q3 2021

Nov 12, 2021

BUY
$13.18 - $19.83 $14.8 Million - $22.3 Million
1,124,500 Added 832.96%
1,259,500 $21.5 Million
Q2 2021

Aug 16, 2021

BUY
$9.59 - $50.88 $1.05 Million - $5.6 Million
110,000 Added 440.0%
135,000 $1.81 Million
Q1 2021

May 17, 2021

SELL
$49.53 - $68.4 $17.2 Million - $23.7 Million
-346,300 Reduced 93.27%
25,000 $1.28 Million
Q2 2020

Aug 14, 2020

BUY
$38.58 - $65.07 $14.1 Million - $23.7 Million
364,200 Added 5129.58%
371,300 $21.4 Million
Q1 2020

May 15, 2020

SELL
$32.73 - $50.78 $448,400 - $695,686
-13,700 Reduced 65.87%
7,100 $285,000
Q4 2019

Feb 13, 2020

SELL
$6.81 - $39.55 $28,602 - $166,110
-4,200 Reduced 16.8%
20,800 $824,000
Q1 2019

May 14, 2019

BUY
$10.01 - $13.89 $250,250 - $347,250
25,000 New
25,000 $348,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.